Table 1 Characteristics of patients included in this study
Characteristic | All data (n = 124) | p value | |
|---|---|---|---|
GIST (n = 90) | Others (n = 34) | ||
Tumor size* | 4.35 ± 2.87 | 3.87 ± 3.35 | 0.484 |
Long/short diameter* | 1.26 ± 0.29 | 1.52 ± 0.61 | 0.032 |
CT value* | 34.18 ± 5.69 | 36.79 ± 9.97 | 0.192 |
Arterial phase enhancement** | 14.60 ± 13.29 | 17.00 ± 13.38 | 0.800 |
Venous phase enhancement** | 34.15 ± 16.63 | 35.85 ± 19.91 | 0.423 |
Homogeneous enhancement* | |||
Yes | 46 | 22 | 0.218 |
No | 33 | 8 | |
Bleeding# | |||
Yes | 9 | 3 | 1.000 |
No | 66 | 28 | |
Ulcer on the surface# | |||
Yes | 12 | 3 | 0.545 |
No | 63 | 28 | |
Calcification inside## | |||
Yes | 7 | 4 | 0.734 |
No | 33 | 15 | |
Liquid area inside## | |||
Yes | 12 | 0 | 0.006 |
No | 28 | 19 | |
White blood cell (× 109/L)+ | 5.74 ± 2.14 | 5.55 ± 1.43 | 0.645 |
Neutrophil (× 109/L)+ | 3.49 ± 1.93 | 3.24 ± 1.33 | 0.475 |
Lymphocyte (× 109/L)+ | 1.62 ± 0.52 | 1.67 ± 0.57 | 0.616 |
Platelet (× 109/L)+ | 219.5 ± 56.50 | 228.00 ± 81.77 | 0.517 |
Haemoglobin (g/L)+ | 129.77 ± 23.78 | 128.29 ± 18.17 | 0.745 |
ALT+ | 21.18 ± 10.86 | 17.09 ± 8.08 | 0.026 |
AST+ | 22.78 ± 10.79 | 20.03 ± 7.30 | 0.173 |
Albmin (g/L)+ | 40.25 ± 3.87 | 40.76 ± 3.53 | 0.501 |
Fibrinogen+ | 302.36 ± 56.55 | 303.50 ± 70.41 | 0.925 |
De Ritis ratio++ | 1.21 ± 0.44 | 1.30 ± 0.52 | 0.324 |
PNI++ | 48.33 ± 5.12 | 49.12 ± 4.34 | 0.428 |
SII++ | 527.31 ± 394.00 | 518.67 ± 400.14 | 0.914 |
PLR++ | 147.67 ± 57.70 | 155.44 ± 93.01 | 0.577 |
NLR++ | 2.42 ± 1.73 | 2.29 ± 1.65 | 0.712 |